NO175369C - Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)-7-(3-amino-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre, en in vivo lett spaltbar lavere alkylester eller et farmasöytisk akseptabelt salt - Google Patents
Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)-7-(3-amino-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre, en in vivo lett spaltbar lavere alkylester eller et farmasöytisk akseptabelt saltInfo
- Publication number
- NO175369C NO175369C NO901391A NO901391A NO175369C NO 175369 C NO175369 C NO 175369C NO 901391 A NO901391 A NO 901391A NO 901391 A NO901391 A NO 901391A NO 175369 C NO175369 C NO 175369C
- Authority
- NO
- Norway
- Prior art keywords
- naphthyridine
- dihydro
- oxo
- amino
- preparing
- Prior art date
Links
- -1 3-Amino-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound 0.000 title 1
- 125000005907 alkyl ester group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/329,461 US4916141A (en) | 1989-03-28 | 1989-03-28 | (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO901391D0 NO901391D0 (no) | 1990-03-27 |
| NO901391L NO901391L (no) | 1990-10-01 |
| NO175369B NO175369B (no) | 1994-06-27 |
| NO175369C true NO175369C (no) | 1994-10-05 |
Family
ID=23285509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO901391A NO175369C (no) | 1989-03-28 | 1990-03-27 | Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)-7-(3-amino-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre, en in vivo lett spaltbar lavere alkylester eller et farmasöytisk akseptabelt salt |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4916141A (fr) |
| EP (1) | EP0394685A3 (fr) |
| JP (1) | JP2948857B2 (fr) |
| KR (1) | KR900014382A (fr) |
| AU (1) | AU617974B2 (fr) |
| CA (1) | CA2013136C (fr) |
| FI (1) | FI94640C (fr) |
| NO (1) | NO175369C (fr) |
| NZ (1) | NZ233087A (fr) |
| PH (1) | PH26185A (fr) |
| PT (1) | PT93571B (fr) |
| ZA (1) | ZA902356B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057520A (en) * | 1989-03-24 | 1991-10-15 | Abbott Laboratories | 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds |
| US5057523A (en) * | 1988-09-22 | 1991-10-15 | Abbott Laboratories | Dipeptide quinolone derivatives |
| US5177217A (en) * | 1992-04-27 | 1993-01-05 | Warner-Lambert Company | Process for the manufacture of (S)-3-amino-1-substituted-pyrrolidines |
| US5290794A (en) * | 1992-10-27 | 1994-03-01 | Warner Lambert Co. | Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms |
| US5977381A (en) * | 1998-01-12 | 1999-11-02 | Hoffmann-La Roche Inc. | Process for making 3-amino-pyrolidine derivatives |
| KR100295740B1 (ko) | 1998-09-17 | 2001-11-05 | 박영구 | N-치환된-하이드록시고리화알킬아민유도체의제조방법 |
| DE60308204T2 (de) * | 2002-08-01 | 2007-08-23 | Basilea Pharmaceutica Ag | Verfahren zur herstellung von aminopyrrolidinderivaten |
| KR100939347B1 (ko) * | 2005-07-20 | 2010-01-29 | (주)카이로드 | 광학적으로 순수한 (s)-3-히드록시 피롤리딘의 제조방법 |
| JP5164842B2 (ja) | 2006-07-28 | 2013-03-21 | 株式会社カネカ | 光学活性3−アミノ含窒素化合物の製造法 |
| US8445700B2 (en) | 2008-11-24 | 2013-05-21 | Council Of Scientific & Industrial Research | Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines |
| EP4382529A1 (fr) | 2022-12-07 | 2024-06-12 | Bayer Consumer Care AG | Procédé de préparation de (3s)-pyrrolidin-3-ol pur et de chlorhydrate de (3s)-pyrrolidin-3-ol pur |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS274601B2 (en) * | 1983-07-27 | 1991-09-15 | Dainippon Pharmaceutical Co | Method of 1,8-naphthyridine derivative production |
| ZA877471B (en) * | 1986-10-08 | 1988-04-05 | Bristol-Myers Company | 1-tertiary-alkyl-substituted naphthyridine-and quinoline-carboxylic acid antibacterial agents |
| US4851418A (en) * | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
| AU5123690A (en) * | 1989-03-13 | 1990-09-13 | Bristol-Myers Squibb Company | 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents |
-
1989
- 1989-03-28 US US07/329,461 patent/US4916141A/en not_active Expired - Lifetime
-
1990
- 1990-03-26 NZ NZ233087A patent/NZ233087A/en unknown
- 1990-03-26 FI FI901505A patent/FI94640C/fi not_active IP Right Cessation
- 1990-03-26 AU AU52197/90A patent/AU617974B2/en not_active Ceased
- 1990-03-27 KR KR1019900004097A patent/KR900014382A/ko not_active Ceased
- 1990-03-27 JP JP2075809A patent/JP2948857B2/ja not_active Expired - Fee Related
- 1990-03-27 EP EP19900105827 patent/EP0394685A3/fr not_active Withdrawn
- 1990-03-27 PH PH40268A patent/PH26185A/en unknown
- 1990-03-27 PT PT93571A patent/PT93571B/pt not_active IP Right Cessation
- 1990-03-27 CA CA002013136A patent/CA2013136C/fr not_active Expired - Fee Related
- 1990-03-27 NO NO901391A patent/NO175369C/no not_active IP Right Cessation
- 1990-03-27 ZA ZA902356A patent/ZA902356B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO901391L (no) | 1990-10-01 |
| PT93571B (pt) | 1996-08-30 |
| ZA902356B (en) | 1991-11-27 |
| NO901391D0 (no) | 1990-03-27 |
| US4916141A (en) | 1990-04-10 |
| FI901505A0 (fi) | 1990-03-26 |
| AU617974B2 (en) | 1991-12-05 |
| EP0394685A3 (fr) | 1991-09-25 |
| FI94640B (fi) | 1995-06-30 |
| CA2013136C (fr) | 1998-09-15 |
| NZ233087A (en) | 1991-07-26 |
| JP2948857B2 (ja) | 1999-09-13 |
| KR900014382A (ko) | 1990-10-23 |
| PT93571A (pt) | 1990-11-07 |
| EP0394685A2 (fr) | 1990-10-31 |
| AU5219790A (en) | 1990-10-04 |
| JPH02289568A (ja) | 1990-11-29 |
| PH26185A (en) | 1992-03-18 |
| CA2013136A1 (fr) | 1990-09-28 |
| FI94640C (fi) | 1995-10-10 |
| NO175369B (no) | 1994-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI890508L (fi) | Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi | |
| FI883807A7 (fi) | Menetelmä farmakologisesti aktiivisten 7-(3-substituoitu-1-pyrrolidinyyli)-1-syklopropyyli-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi | |
| FI20000085L (fi) | Menetelmä terapeuttisesti aktiivisten 4-amino-substituoitujen 2-azabicyklo/3.3.1/nonaanijohdannaisten valmistamiseksi | |
| NO175531C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazo(4,5-b)-kinolinyloksyalkansyreamider | |
| NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
| HUT45515A (en) | Process for producing benzoxazine and benzthiazine acetic acid derivatives and pharmaceutics comprising these compounds as active ingredient | |
| CS666688A2 (en) | Method of 7 beta-/2-(r)-2-phenyl-2-aminoacetamide)-3-chloro-3-(1-carbadethiacephem)-4-carboxylic acid's crystalline monohydrate form preparation | |
| FI922848L (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia tetrahydropyrrolo[1,2-a]pyratsiini-4-spiro-3'-pyrrolidiinijohdannaisia | |
| NO175369C (no) | Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)-7-(3-amino-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre, en in vivo lett spaltbar lavere alkylester eller et farmasöytisk akseptabelt salt | |
| NO174959C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater | |
| EP0487986A3 (en) | Process for the preparation of esters of (6s)-6,8-dihydroxyoctanoic acid | |
| IL53757A (en) | Imidazo(1,2-a)quinoline-2-carboxylic acids,their esters and salts,process for preparing them and pharmaceutical compositions containing them | |
| IE882255L (en) | Preparation of quinolonecarboxylic acids | |
| AR245125A1 (es) | Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y sus sales de adicion de acidos farmaceuticamente aceptables. | |
| FI882002L (fi) | Menetelmä terapeuttisesti aktiivisten fenyylipiperidiinijohdannaisten valmistamiseksi | |
| HUT40667A (en) | Process for preparing new thieno/2,3-d/imidazole derivatives and pharmaceutically acceptable acid addition salts thereof | |
| FI900145A0 (fi) | Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi | |
| FI894506L (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia pyrido/1,2-a/indolijohdannaisia | |
| HUT43571A (en) | Process for preparing quinolone carboxylic acid derivatives | |
| FI883248A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi | |
| HUT43554A (en) | Process for preparing new benzoyl acetic acid ester derivatives | |
| FI905930A7 (fi) | Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi | |
| FI93216C (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi | |
| TR24836A (tr) | PIRIDIN KARBOKSILIK ASIT TüREVLERININ HAZIRLANMASI ICIN PROSES | |
| NO174887C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive aryl- alkyl-pyrrol-2-carboxylsyreforbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |